Antimicrobial activity and antifungal mechanistic study of 3‑substituted oxindoles against Aspergillus niger

1. Rudramurthy, S. M., Paul, R. A., Chakrabarti, A., Mouton, J. W. & Meis, J. F. Invasive aspergillosis by Aspergillus flavus: epidemiology, diagnosis, antifungal resistance, and management. J. Fungi 5(3), 55 (2019).

   Google Scholar 

2. Sugui, J. A. et al. Genetic relatedness versus biological compatibility between Aspergillus fumigatus and related species. J. Clin. Microbiol. 52(10), 3707–3721 (2014).

   Google Scholar 

3. Brilhante RSmN, Rodrigues TdJS, Castelo-Branco DdSCM, Teixeira CEC, Macedo RdB, Bandeira SP, Pereira de Alencar L, Monteiro AJ, Cordeiro RdA, Bandeira TdJPG: Antifungal susceptibility and virulence attributes of animal-derived isolates of Candida parapsilosis complex. J. Med. Microbiol. 2014, 63(11):1568–1572.

4. Ferreira, E. S. et al. Antifungal activity and mechanism of action of 2-chloro-N-phenylacetamide: A new molecule with activity against strains of Aspergillus flavus. An. Acad. Bras. Ciênc. 93(suppl 3), e20200997 (2021).

   Google Scholar 

5. Tomee, K. Putative virulence factors of Aspergillus fumigatus. Clin. Exp. Allergy 30(4), 476–484 (2000).

   Google Scholar 

6. Latgé, J.-P. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 12(2), 310–350 (1999).

   Google Scholar 

7. Singh G, Urhekar A: Virulence factors detection in Aspergillus isolates from clinical and environmental samples. J. Clin. Diagnostic Res: JCDR 2017, 11(7):DC13.

8. Bondy, G. S. & Pestka, J. J. Immunomodulation by fungal toxins. J. Toxicol. Environ. Health Part B 3(2), 109–143 (2000).

   Google Scholar 

9. Miceli, M. H. & Lee, S. A. Emerging moulds: epidemiological trends and antifungal resistance. Mycoses 54(6), e666–e678 (2011).

   Google Scholar 

10. Robbins, N., Caplan, T. & Cowen, L. E. Molecular evolution of antifungal drug resistance. Annu. Rev. Microbiol. 71(1), 753–775 (2017).

    Google Scholar 

11. Castelo-Branco DdSCM, Paiva MdAN, Teixeira CEC, Caetano ÉP, Guedes GMdM, Cordeiro RdA, Brilhante RSN, Rocha MFG, Sidrim JJC: Azole resistance in Candida from animals calls for the One Health approach to tackle the emergence of antimicrobial resistance. Med. Mycol. 2020, 58(7):896-905

12. Berman, J. & Krysan, D. J. Drug resistance and tolerance in fungi. Nat. Rev. Microbiol. 18(6), 319–331 (2020).

    Google Scholar 

13. Khetmalis, Y. M., Shivani, M., Murugesan, S. & Sekhar, K. V. G. C. Oxindole and its derivatives: A review on recent progress in biological activities. Biomed. Pharmacother. 141, 111842 (2021).

    Google Scholar 

14. Strigácová, J. et al. Novel oxindole derivatives and their biological activity. Folia Microbiol. 46(3), 187–192 (2001).

    Google Scholar 

15. Singh, S., Rehman, S., Fatima, Z. & Hameed, S. Protein kinases as potential anticandidal drug targets. Front. Biosci.-Landmark 25(8), 1412–1432 (2020).

    Google Scholar 

16. Ölgen, S. & Özkan, S. A study of 3-substituted benzylidene-1, 3-dihydro-indoline derivatives as antimicrobial and antiviral agents. Zeitschrift für Naturforschung C 64(3–4), 155–162 (2009).

    Google Scholar 

17. Kaplancikli, Z. A. Synthesis of some oxadiazole derivatives as new anticandidal agents. Molecules 16(9), 7662–7671. https://doi.org/10.3390/molecules16097662 (2011).

    Google Scholar 

18. Ezelarab, H. A. A. et al. New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization. Mol Divers 28, 563–580 (2024).

    Google Scholar 

19. Gow NA, Latge J-P, Munro CA: The fungal cell wall: structure, biosynthesis, and function. Microbiol. Spectrum 2017, 5(3):https://doi.org/10.1128/microbiolspec. funk-0035–2016.

20. Lima, S. L., Colombo, A. L. & de Almeida Junior, J. N. Fungal cell wall: emerging antifungals and drug resistance. Front. Microbiol. 10, 2573 (2019).

    Google Scholar 

21. Lesage, G. & Bussey, H. Cell wall assembly in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 70(2), 317–343 (2006).

    Google Scholar 

22. Denning, D. W. Echinocandin antifungal drugs. The Lancet 362(9390), 1142–1151 (2003).

    Google Scholar 

23. Shelkar, P. L., Mali, P. P., Waghulde, S. O., Gadekar, S. S. & Sapkal, S. B. Synthesis, characterization, and molecular docking studies of new biologically active aryl, heteroaryl, and carboxamide piperazine derivatives of β-amino sulfone. J. Mol. Struct. 1326, 141096 (2025).

    Google Scholar 

24. Pătruică, S. et al. Romanian bee product analysis: Chemical composition, antimicrobial activity, and molecular docking insights. Foods 13(10), 1455 (2024).

    Google Scholar 

25. Liu, W., Yuan, L. & Wang, S. Recent progress in the discovery of antifungal agents targeting the cell wall. J. Med. Chem. 63(21), 12429–12459 (2020).

    Google Scholar 

26. Zhou, Y. & Reynolds, T. B. Innovations in antifungal drug discovery among cell envelope synthesis enzymes through structural insights. Journal of Fungi 10(3), 171 (2024).

    Google Scholar 

27. Zhao C-R, You Z-L, Chen D-D, Hang J, Wang Z-B, Ji M, Wang L-X, Zhao P, Qiao J, Yun C-H: Structure of a fungal 1, 3-β-glucan synthase. Sci. Adv. 2023, 9(37):eadh7820.

28. Saini V, Safwan SM, Mehta D, Das EE, Bajaj A: Recent Advances in the Development of Antifungal Agents: Beyond Azoles, Polyenes, and Echinocandins. ACS Infectious Diseases 2025.

29. Borman, A. M. et al. MIC distributions and evaluation of fungicidal activity for amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin and 20 species of pathogenic filamentous fungi determined using the CLSI broth microdilution method. J. Fungi 3(2), 27 (2017).

    Google Scholar 

30. Coutinho, H. D., Costa, J. G., Lima, E. O., Falcão-Silva, V. S. & Siqueira-Júnior, J. P. Enhancement of the antibiotic activity against a multiresistant Escherichia coli by Mentha arvensis L. and chlorpromazine. Chemotherapy 54(4), 328–330 (2008).

    Google Scholar 

31. Escalante, A., Gattuso, M., Pérez, P. & Zacchino, S. Evidence for the mechanism of action of the antifungal phytolaccoside B isolated from Phytolacca tetramera Hauman. J. Nat. Prod. 71(10), 1720–1725 (2008).

    Google Scholar 

32. Leite, M. C. A., Bezerra, A. P. D. B., Sousa, J. P. D., Guerra, F. Q. S., & Lima, E. D. O. Evaluation of antifungal activity and mechanism of action of citral against Candida albicans. Evidence-Based Complementary Alternative Medicine 2014, 2014(1):378280

33. Roy C: Evaluation of new antimicrobials in vitro and in experimental animal infection. Antibiotics in laboratory medicine 1991.

34. Hadacek, F. & Greger, H. Testing of antifungal natural products: methodologies, comparability of results and assay choice. Phytochem. Anal.: Int. J. Plant Chem. Biochem. Techn. 11(3), 137–147 (2000).

    Google Scholar 

35. Granada, D. L. & Skariyachan, S. P U: In vitro and In silico investigation deciphering novel antifungal activity of endophyte Bacillus velezensis CBMB205 against Fusarium oxysporum. Sci. Rep. 15(1), 684 (2025).

    Google Scholar 

36. Antypenko L, Meyer F, Sadyk Z, Shabelnyk K, Kovalenko S, Steffens KG, Garbe L-A: Combined Application of Tacrolimus with Cyproconazole, Hymexazol and Novel {2-(3-R-1 H-1, 2, 4-triazol-5-yl) phenyl} amines as Antifungals: In Vitro Growth Inhibition and In Silico Molecular Docking Analysis to Fungal Chitin Deacetylase. J. Fungi 2023, 9(1):79.

Download references